Insider filing · RGNX
Curran Simpson
Chief Executive Officer
profile →
REGENXBIO Inc.
RGNX · Healthcare · 6 filings in 24 months
ticker →
Curran Simpson sold $263K of REGENXBIO (RGNX)
Executed Oct 9 2025, disclosed Oct 10 2025, 1 day later.
Value, as filed
$263K
20,811 sh × $12.62
Executed
Oct 9 2025
the trade date, as filed
Disclosed
Oct 10 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CSCurran Simpson (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in REGENXBIO Inc. (RGNX). The largest single filing was $263K of RGNX (20,811 sh × $12.62, as filed), executed Oct 9 2025.
The name
RGNXHealthcare · REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→